The Food and Drug Administration has set March 8 as the end of its emergency use authorization (EUA) for Paxlovid for adult patients, the agency has said this week. The medication is given to those ...

Transitioning COVID-19 tests from emergency use authorization to the traditional pre-market pathway has long been a goal for the FDA. “Today’s authorization is the first at-home COVID-19 test granted ...

Please provide your email address to receive an email when new articles are posted on . The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of the virus. The ...

The COVID-19 public health emergency’s end doesn’t affect the U.S. Food and Drug Administration’s authority to issue new emergency use authorizations related to the novel coronavirus. That’s because a ...